
Jeplus.in
Purchase All Medicines.Get 10% Offer

Pharma Tech
At IDWeek 2026, Akimasa Fukushi from Shionogi presented a subpopulation analysis of the Phase III SCORPIO-PEP trial.

Pharma Tech
At IDWeek 2026, Samir K Gupta presented a pooled analysis of the Phase III ISLEND-1 and ISLEND-2 trials evaluating once-weekly ISL/LEN in adults with virologically suppressed HIV.

Pharma Tech
Legal experts say that pharma outcome bets on platforms like Kalshi and Polymarket pose new insider trading risks.

PharmaShots
Shots: Note: Ranks and companies are shown with FY2025 revenue of the qualifying skin care, dermocosmetics, sun care or aesthetics line in USD M, converted at 31 December 2025 exchange rates. Growth for every company is shown below. 20. Bloomage Biotech Skin Segment Revenue: $0.35B Qualifying Line: Skin science innovation (functional skincare) and skin-type medical⊠The post Top 20 Skincare and Dermocosmetics Companies of 2026 appeared first on PharmaShots.

Pharma Tech
Following this MHRA label expansion, UK patients with ÎČ-thalassemia and sickle cell disease aged five and up can now receive Casgevy.
Sponsored content

Purchase All Medicines.Get 10% Offer
News
ET Pharma
Oct 31, 2026, 8:37 AM
â On a press call, executives said some departments face cutbacks or restructuring, while others will re-skill and hire for emerging needs. Soriot said shifting âfocus from patent-expiring drugs such as Farxiga and Brilinta to oncology and rare diseases could render some R&D roles redundant.
ET Pharma
Oct 30, 2026, 11:28 PM
Speaking to analysts, Kirti Ganorkar MD, Sun Pharma said, "there are 11 ophthalmology products which we have voluntarily recalled. We voluntarily initiated a temporary cessation of our manufacturing activities, and we have kept the Indian regulator informed about it.â
Pharma Tech
Oct 30, 2026, 4:38 PM
At IDWeek 2026, Akimasa Fukushi from Shionogi presented a subpopulation analysis of the Phase III SCORPIO-PEP trial.
Pharma Tech
Oct 30, 2026, 4:28 PM
At IDWeek 2026, Samir K Gupta presented a pooled analysis of the Phase III ISLEND-1 and ISLEND-2 trials evaluating once-weekly ISL/LEN in adults with virologically suppressed HIV.
Pharma Tech
Oct 30, 2026, 2:26 PM
Legal experts say that pharma outcome bets on platforms like Kalshi and Polymarket pose new insider trading risks.
PharmaShots
Oct 30, 2026, 1:38 PM
Shots: Ref: Roche |  Image: Roche  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Roche Launches Ventana BAP1 (SP527) Assay to Improve Mesothelioma Diagnosis appeared first on PharmaShots.
News
Google News
Oct 31, 2026, 5:16 PM
Silica Gel Market To 2035: Electronics and Pharma Demand Drive Growth - News and Statistics  IndexBox
Google News
Oct 31, 2026, 3:11 PM
Oxygen Absorbers Market To 2035: Demand Accelerates on Packaged Food and Pharma Preservation - News and Statistics  IndexBox
Google News
Oct 31, 2026, 2:49 PM
Cancer Drug Price Cuts Expose Wider Gaps In India's Medicine Pricing System  Outlook India
Google News
Oct 31, 2026, 2:44 PM
Sun Pharma ESOP 2026 and Borrowing Limit Approved by Shareholders  Kalkine India
Google News
Oct 31, 2026, 1:05 PM
Sun Pharma Profit Falls on Organon Deal Costs  Unique Times Magazine
Google News
Oct 31, 2026, 12:26 PM
Granules India Receives 11 USFDA Observations at Gagillapur Facility  Medical Dialogues
Google News
Oct 31, 2026, 12:17 PM
Alembic Pharma Gets USFDA Nod for Generic Cancer Drug Venetoclax  Medical Dialogues
Google News
Oct 31, 2026, 11:44 AM
Pharma company Gufic buys luxury duplex in Mumbaiâs Juhu for over Rs 236 cr  The Economic Times
Google News
Oct 31, 2026, 11:10 AM
Goa Vibrant Summit -2026 to offer African nations investment opportunities in pharma, medtech and other manufacturing sectors: Goa CM Dr Pramod Sawant  Pharmabiz.com
Sponsored placement

Purchase All Medicines.Get 10% Offer